Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-24 @ 11:28 PM
Ignite Modification Date:
2025-12-25 @ 9:15 PM
NCT ID:
NCT00720356
Group ID:
EG000
Title:
Erlotinib and Bevacizumab Combination Treatment
Description:
Erlotinib and bevacizumab
Bevacizumab: 10mg/kg administered intravenously every 2 weeks
Erlotinib hydrochloride: 150 mg/daily orally
Deaths Number Affected:
43
Deaths Number At Risk:
None
Serious Number Affected:
15
Serious Number At Risk:
48
Other Number Affected:
48
Other Number At Risk:
48
Study:
NCT00720356
Results Section:
NCT00720356
Adverse Events Module:
NCT00720356